To investigate to prevalence and seroconversion rate of SARS-CoV-2 antibodies in a German cohort of MSM using HIV PrEP, Germany, over a time period of one year following the first outbreak of the covid pandemic.
8. February 2022
To investigate to prevalence and seroconversion rate of SARS-CoV-2 antibodies in a German cohort of MSM using HIV PrEP, Germany, over a time period of one year following the first outbreak of the covid pandemic.
Overview of SARS-COV-2 studies seroprevalence in context of the worldwide COVID-19 pandemie. You can register a study here: Contribute
serohub@helmholtz-hzi.de
@serohub on Twitter
hzi-braunschweig/serohub on GitHub